CD79B and primary central nervous system lymphoma: Our PCLBCL, LT cases exhibited a mutational profile resembling that of PCNSL, with a high rate (80%) of mutations in the TLR MYD88 pathway and/or CD79B and TNFAIP3/A20 [14, 15].